Literature DB >> 9818971

Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization.

A Tomasz1, A Corso, E P Severina, G Echániz-Aviles, M C Brandileone, T Camou, E Castañeda, O Figueroa, A Rossi, J L Di Fabio.   

Abstract

The Pan American Health Organization (PAHO) has conducted a study of Streptococcus pneumoniae in six Latin-American countries: Argentina, Brazil, Chile, Colombia, Mexico, and Uruguay. Sterile site isolates from children aged < or =5 years showing clinical symptoms of pneumonia (as defined by the clinical criteria of WHO), meningitis, sepsis or bacteremia (without infectious foci), arthritis, and peritonitis were the source of most of the invasive pneumococcal isolates collected between the end of 1993 and 1996 in the six participating countries. Partial characterization of these isolates (antibiotic resistance and serotyping) have already been described (Microbial Drug Resistance 3:(2):131-163, 1997). In the next phase of the study, 326 S. pneumoniae isolates with reduced penicillin susceptibility were transferred to the Laboratory of Microbiology at The Rockefeller University for molecular characterization, and a summary and overview of the findings is described in this article. Some of the most interesting findings were as follows: (1) There was a surprisingly high representation of two internationally spread clones, which made up >80% of the strains with penicillin MIC of 1 microg/ml or higher; most of these isolates were recovered in large cities, supporting the likelihood that the source of these clones is through international travel. (2) The frequency of resistance to trimethoprim/sulfamethoxazole was extremely high (present in 85% of all isolates with decreased penicillin susceptibility). (3) None of these isolates was resistant to ofloxacin, and macrolide resistance was rare (present in 6.4% of the isolates). (4) There was an apparent inverse relationship between level of penicillin resistance and genetic diversity. (5) There were striking differences in the "microbiologic profiles" of the six different Latin-American countries.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818971     DOI: 10.1089/mdr.1998.4.195

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  28 in total

1.  Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel.

Authors:  N Porat; R Trefler; R Dagan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Molecular epidemiology of penicillin-nonsusceptible Streptococcus pneumoniae among children in Greece.

Authors:  D Bogaert; G A Syrogiannopoulos; I N Grivea; R de Groot; N G Beratis; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones.

Authors:  L Alou; M Ramirez; C García-Rey; J Prieto; H de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Antimicrobial susceptibilities and serotype distribution of Streptococcus pneumoniae isolates from a Low socioeconomic area in Lima, Peru.

Authors:  Anna R Cullotta; H D Kalter; Jose Delgado; Robert H Gilman; Richard R Facklam; Billie Velapatino; Jorge Coronel; Lilia Cabrera; M Urbina
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam.

Authors:  D Bogaert; N T Ha; M Sluijter; N Lemmens; R De Groot; P W M Hermans
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 7.  The CEM-NET initiative: molecular biology and epidemiology in alliance--tracking antibiotic-resistant staphylococci and pneumococci in hospitals and in the community.

Authors:  Herminia de Lencastre; Alexander Tomasz
Journal:  Int J Med Microbiol       Date:  2011-10-13       Impact factor: 3.473

8.  Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal.

Authors:  I Serrano; J Melo-Cristino; J A Carriço; M Ramirez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

9.  Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.

Authors:  Tatiana C A Pinto; Fabíola C O Kegele; Cícero A G Dias; Rosana R Barros; José M Peralta; Vânia L C Merquior; Maria da Gloria Carvalho; Sopio Chochua; Paulina Hawkins; Lesley McGee; Lucia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

10.  Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria.

Authors:  L Setchanova; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.